Abstract | BACKGROUND: METHODS: Here we used cell culture systems, a mouse lupus model, and material from lupus patients, to explore the mode of action of a STING antagonistic peptide, and its ability to modulate disease processes. FINDINGS: We report that the peptide ISD017 selectively inhibits all known down-stream activities of STING, including IFN-I, inflammatory cytokines, autophagy, and apoptosis. ISD017 blocks the essential trafficking of STING from the ER to Golgi through a mechanism dependent on the STING ER retention factor STIM1. Importantly, ISD017 blocks STING activity in vivo and ameliorates disease development in a mouse model for lupus. Finally, ISD017 treatment blocks pathological cytokine responses in cells from lupus patients with elevated IFN-I levels. INTERPRETATION: These data hold promise for beneficial use of STING-targeting therapy in lupus. FUNDING: The Novo Nordisk Foundation, The European Research Council, The Lundbeck Foundation, European Union under the Horizon 2020 Research, Deutsche Forschungsgemeinschaft, Chulalongkorn University.
|
Authors | Thaneas Prabakaran, Anne Troldborg, Sarinya Kumpunya, Isara Alee, Emilija Marinković, Samuel J Windross, Ramya Nandakumar, Ryo Narita, Bao-Cun Zhang, Mikkel Carstensen, Pichpisith Vejvisithsakul, Mikkel H S Marqvorsen, Marie B Iversen, Christian K Holm, Lars J Østergaard, Finn Skou Pedersen, Trairak Pisitkun, Rayk Behrendt, Prapaporn Pisitkun, Søren R Paludan |
Journal | EBioMedicine
(EBioMedicine)
Vol. 66
Pg. 103314
(Apr 2021)
ISSN: 2352-3964 [Electronic] Netherlands |
PMID | 33813142
(Publication Type: Journal Article)
|
Copyright | Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved. |
Chemical References |
- Membrane Proteins
- Neoplasm Proteins
- STIM1 protein, human
- STING1 protein, human
- Stromal Interaction Molecule 1
|
Topics |
- Animals
- Cell Line
- Disease Models, Animal
- Disease Susceptibility
- Endoplasmic Reticulum
(metabolism)
- Extracellular Vesicles
(metabolism)
- Gene Expression
- Golgi Apparatus
(metabolism)
- Humans
- Lupus Erythematosus, Systemic
(drug therapy, etiology, metabolism, pathology)
- Membrane Proteins
(antagonists & inhibitors)
- Mice
- Mice, Knockout
- Neoplasm Proteins
(metabolism)
- Protein Transport
(drug effects)
- Stromal Interaction Molecule 1
(metabolism)
|